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Abstract
Background: In the treatment of phenylketonuria (PKU), there was disparity between UK dietitians regarding
interpretation of how different foods should be allocated in a low phenylalanine diet (allowed without measurement,
not allowed, or allowed as part of phenylalanine exchanges). This led to variable advice being given to patients.
Methodology: In 2015, British Inherited Metabolic Disease Group (BIMDG) dietitians (n = 70) were sent a multiple-
choice questionnaire on the interpretation of protein from food-labels and the allocation of different foods. Based
on majority responses, 16 statements were developed. Over 18-months, using Delphi methodology, these statements
were systematically reviewed and refined with a facilitator recording discussion until a clear majority was attained for
each statement. In Phase 2 and 3 a further 7 statements were added.
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Results: The statements incorporated controversial dietary topics including: a practical ‘scale’ for guiding calculation of
protein from food-labels; a general definition for exchange-free foods; and guidance for specific foods. Responses were
divided into paediatric and adult groups. Initially, there was majority consensus (≥86%) by paediatric dietitians (n = 29)
for 14 of 16 statements; a further 2 structured discussions were required for 2 statements, with a final majority
consensus of 72% (n = 26/36) and 64% (n = 16/25). In adult practice, 75% of dietitians agreed with all initial statements
for adult patients and 40% advocated separate maternal-PKU guidelines. In Phase 2, 5 of 6 statements were agreed by
≥76% of respondents with one statement requiring a further round of discussion resulting in 2 agreed statements with
a consensus of ≥71% by dietitians in both paediatric and adult practice. In Phase 3 one statement was added to
elaborate further on an initial statement, and this received 94% acceptance by respondents. Statements were endorsed
by the UK National Society for PKU.
Conclusions: The BIMDG dietitians group have developed consensus dietetic statements that aim to harmonise dietary
advice given to patients with PKU across the UK, but monitoring of statement adherence by health professionals
and patients is required.
Keywords: Phenylketonuria (PKU), Delphi method, Food labelling, Consensus, Phenylalanine exchanges
Introduction
Phenylketonuria (PKU) is an inborn error of amino acid
metabolism, due to deficiency or absence of the enzyme
phenylalanine hydroxylase, leading to accumulation of
blood and brain phenylalanine (Phe). Untreated, it will
cause severe, irreversible neurological damage [1]. Strict
dietary management is the only available treatment
option in the UK. The aim is to correct abnormal bio-
chemistry by decreasing the Phe load on the affected
pathway and supplementation with Phe -free L-amino
acids or low Phe glycomacropeptide protein substitutes
[2]. The diet involves avoiding high protein foods (e.g.
meat, fish, eggs, cheese, seeds, flour, bread and nuts),
with strict control of moderate containing protein foods
(e.g. cereals, potato, milk and some vegetables) to main-
tain blood Phe levels within target range [1, 3]. Several
fruits and vegetables are low in Phe and are incorporated
in the diet without limit [4]. From weaning when solids
are first introduced [5] and later with the ever growing
convenience food market, patients with PKU and their
caregivers need simple, consistent, easy-to-understand
rules for calculating protein intake. A national dietetic
re-appraisal of some of the practical dietary advice given
to UK patients and families with PKU was necessary
because of: the recent publication of European PKU
guidelines identifying different criteria for the allocation
of fruit and vegetables in a low Phe diet [3]; introduction
of new species of fruits and vegetables; new European
protein labelling legislation [6]; contradictory informa-
tion available via social media; and increasing patient
usage of manufactured foods.
The British Inherited Metabolic Diseases (BIMDG) Di-
etitians Group, using the Delphi method set out to agree
a set of practical statements about the classifications of
foods in a low Phe diet. The Delphi process is a tool
used to gain a majority decision in a structured or sys-
tematic manor. It helps secure a collective view from a
panel of experts about complex issues or problems
where there is little or no definitive evidence [7, 8].
Experts respond to questionnaires over several rounds
with a facilitator coordinating and summarising re-
sponses for feedback. Responses and feedback from each
expert, guide the questions for further rounds. With
each successive round the number of questions declines
as the group moves toward consensus.
Aims
To develop consensus statements about the practical
allocation of foods and interpretation of protein food la-
belling in a low Phe diet for the management of PKU in
the UK using the Delphi method to generate consensus.
Methods
In November 2015, BIMDG dietitians convened to dis-
cuss the allocation of foods and interpretation of food la-
beling with the aim of developing consensus statements
for PKU. A multiple-choice questionnaire, comprising
14 questions about dietary advice to UK patients or
caregivers regarding the allocation of different foods
(allowed without measurement, not allowed, or allowed
as part of Phe exchanges) and interpretation of protein
from food labels, was distributed to 70 BIMDG dietitians
from 30 centres treating individuals with PKU. The re-
sults of this questionnaire identified 7 specific areas
where dietetic practice was variable, leading to contra-
dictory advice being issued to patients and caregivers.
These 7 areas are identified in Table 1.
Following a round table discussion of these results at a
BIMDG dietitians meeting, 16 consensus statements for
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the practical dietary management of PKU were put for-
ward and agreed in Phase 1. In Phase 2 a further 6 state-
ments, and in Phase 3 one final statement was proposed.
The Delphi method was then used to gain consensus
from the BIMDG dietitians about each of the state-
ments. The lead author acted as facilitator.
The 23 consensus statements on practical dietary
management were circulated to all BIMDG dietitians
by email. A written response of agreement or disagree-
ment with each statement was then returned to the
facilitator for analysis. After each round of circulation,
a telephone conference was held with the BIMDG die-
titians to provide collective feedback and the draft
consensus statements were further adapted. Modified
statements were then recirculated to the BIMDG dieti-
tians with additional questions until a majority decision
(> 60%) was obtained on each statement. Dietitians were
given 8 weeks to respond in each Delphi round.
Approval of the final consensus statements was
sought and received by the UK National Society for
PKU (NSPKU).
Results
Phase 1: Round 1 of Delphi method
The 16 draft consensus statements on practical dietary
management were prepared with accompanying notes
explaining their rationale. They were then distributed for
approval or non-approval of each statement to all BIMDG
dietitians (73 dietitians: 43 paediatric practice, 20
adult practice and 10 caring for both adult and paedi-
atric patients; from 30 inherited metabolic disorder
[IMD] centres).
Replies were received from 40 dietitians (55% of
BIMDG dietitians, from 23 centres, 77%) and results
were distributed to all dietitians within 5 months of ini-
tial circulation. After the first round, there was majority
consensus by paediatric dietitians (≥86%; n = 29) and
dietitians working in adult practice (≥65%; n = 17) for
all 16 statements. At a BIMDG dietitians group tele-
conference, minor modifications were made to a small
number of the consensus statements and 14 of the 16
statements were formerly agreed by paediatric dietitians
(Tables 2 and 3).
However, two of the statements generated consider-
able debate, so it was decided to further explore individ-
ual opinions on these 2 statements following additional
investigation into the Phe content of the products. In
addition, there was some disparity among dietitians
working in adult practice in relation to maternal patients
with PKU and Phe consumption from fruits and vegeta-
bles permitted without measurement. Consequently, it
was decided that for round 2 of the Delphi process,
paediatric dietitians and dietitians working in adult prac-
tice would separate to examine issues independently.
Phase 1: Round 2 of Delphi method
The remaining 2 ‘non-agreed’ draft consensus state-
ments (statement 1: the upper protein content of soya
sauces allowed as an exchange-free food; and state-
ment 2: the allocation of fruits and vegetables contain-
ing Phe content from 76 to 99 mg per 100 g weight)
were modified following examination of barriers to
acceptance (Table 2). An in-depth investigation was
conducted about the protein content of all commercial
soya sauces available to purchase as well as issuing
analysis about the Phe content of fruits and vegetables.
These 2 consensus statements were then recirculated
to the BIMDG dietitians; with 3 possible options for
each statement.
Soya sauce was considered differently to other table
top sauces. Its protein content is highly variable from
< 0.5 g per 100 ml up to 15 g per 100 ml. Soya sauce
option 1: protein ≤ 1 g per 100 ml is exchange-free,
was consistent with the statement for wet cooking
sauces but allowed very little brand choice; option 2:
protein ≤ 1.5 g per 100 ml is exchange-free, allowed more
choice but was inconsistent with statements for other
foods; and option 3: up to 2 tablespoons per day of any
soya sauce, allowed a wide choice of brands but could lead
to a higher protein intake.
Table 1 Variation in dietary advice given to patients by BIMDG
dietitians
Areas of variation in dietary advice given to patients by BIMDG
dietitians:
Use of different terminology to describe low protein foods that could
be incorporated into the diet without measurement.
Inconsistent advice to parents about the calculation of 1 g protein
exchanges (equivalent to 50 mg phenylalanine) from protein labelling
analysis of individual food portions i.e. dietitians were either rounding
protein values > or < 1 g to the nearest 0.5 exchange.
Use of different upper protein ‘cut off’ points for foods that could be
given in the diet without measurement (exchange-free). There was
inconsistent allocation of the following foods: herbs and spices; fats/
oils; soya sauce; gravy; cooking sauces; vegetable crisps; sweets; and
processed vegetables/vegetable sauces with protein containing
ingredients (e.g. milk/wheat).
Inconsistent allocation of manufactured foods that contained low protein
(exchange-free) ingredients.
Inconsistent allocation of special low protein foods that contained low
protein (exchange-free) ingredients.
Inconsistent allocation of fruits and vegetables (containing phenylalanine
from 50 to 100 mg/100 g weight) in the diet. Some dietitians were
allowing certain fruits and vegetables in the diet without measurement;
others were permitting in restricted amounts only.
Inconsistent interpretation of manufactured food labelling: e.g. some
foods are labelled as containing 0 g protein even though some of the
ingredients are protein sources. This includes foods containing protein
≤0.5 g/100 g (permissible by European law: Regulation (EU) No 1169/
2011) [4] or protein < 1 g/100 g (permissible by USA law).
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For fruit and vegetables with a Phe content between 76
to 99 mg per 100 g: option 1: count as part of the 50 mg
Phe exchange system, considered that their uncontrolled
consumption may increase dietary Phe intake consider-
ably, but may be difficult to enforce in patients already
established on dietary management who do not currently
restrict their intake. Option 2: permit only one serving
daily of any fruits and vegetables in this category, but
calculate Phe intake from any additional servings of fruits
and vegetables from this category, overcame some of the
issues associated with option 1, but was complex for both
dietitians and patients or caregivers. Option 3: permit 1
portion daily of any one of the fruits and vegetable in this
category, was the existing guidance and whilst aiming to
control overall intake, it did not consider increased oppor-
tunities for consumption of some of the more novel forms
of these fruits and vegetables e.g. vegetable rice, vegetable
pasta. An additional question was asked in this round
(Table 2) about the acceptance of a standard exchange
weight i.e. 60 g for fruits and vegetables with a Phe con-
tent between 76 and 100 mg per 100 g.
For BIMDG paediatric dietitians, option 2 for the
soya sauce consensus statement received a majority
response (67% of respondents; n = 24/36) and was
agreed; but opinion was divided between the 3 options
for the final consensus statement on fruits and vegeta-
bles containing Phe content from 76 to 99 mg per
100 g weight. However, there was consensus on the
need for a standard exchange weight for these fruits
and vegetables (Table 4). The dietitians working in
adult practice continued to debate both questions but
did not reach consensus at this round.
Phase 1: Round 3 of Delphi method
The remaining ‘non-agreed’ consensus statement concern-
ing the allocation of fruits and vegetables was reissued
with the 2-options scoring highest in the previous round.
Option 1 statement was finally agreed by 64% (n = 25) of
paediatric dietitians and endorsed at the dietitians BIMDG
teleconference in February 2017.
In the final Delphi round, 75 % of dietitians working
in adult practice (n = 15) agreed with the 16 consensus
statements for adult patients following diet, concluding
that consistency in dietary care in the transition from
paediatric to adult services was important. However,
40% (n = 8) of dietitians working in adult practice pro-
posed that separate maternal PKU consensus statements
were required.
NSPKU endorsement
The initial consensus statements were endorsed by the
UK National Society for PKU (NSPKU) in April 2017.
Phase 2: Round 1of Delphi method
Additional food items not covered by the initial statements
were identified in the 6 months following completion of
Phase 1, so 6 new statements on: low protein milks, soups,
coconut desserts, coconut products, ice-cream and gelatine
containing products, were distributed with accompanying
notes. Replies were received from 25 dietitians (from 18
centres) and results were discussed at a BIMDG dietitians
group teleconference in January 2018. There was majority
consensus by dietitians (≥76%) for all but the low protein
milks statement which it was agreed needed redefining
(Table 2).
Phase 2: Round 2 of Delphi method
Two amended statements on plant milks and low protein
milk replacements were sent out in February 2018 and re-
sults discussed and agreed at a teleconference in May
Table 3 Calculating food protein exchanges from protein
analysis on the food label
Protein content per item when
calculated from label
Calculated exchange
0 g protein per food portion Exchange free
0.1 g protein per food portion Exchange free (if total volume
consumed is ≤0.5 g protein)
0.2 g protein per food portion Exchange free (if total volume
consumed is ≤0.5 g protein)
0.3 g protein per food portion Exchange free (if total volume
consumed ≤0.5 g protein).
Suggest 1 portion is exchange-
free, 2 portions is ½ exchangea
0.4 to 0.7 g protein per food portion ½ exchange protein
0.8 to 1.2 g protein per food portion 1 exchange protein
1.3 to 1.7 g per food portion 1.5 exchange protein
1.8 to 2.2 g per food portion 2 exchange protein
2.3 to 2.7 g per food portion 2.5 exchange protein
2.8 to 3.2 per food portion 3 exchange protein
aThis may apply to ice cream lollies, gluten-free cakes, very small packets
crisps, sweets
Table 4 New exchanges (previously exchange free)
Fruit and vegetables containing Phe ≥ 76 mg/100 g Amount for 1
exchange
Figs 60 g
Asparagus 60 g
Beansprouts 60 g
Broccoli 60 g
Brussel sprouts 60 g
Cauliflower 60 g
Yam 60 g
Sugar snap peas 60 g
Mange tout 60 g
Whole hearts of palm 60 g
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2018. There were 30 replies and 77% (n = 23) agreed with
the plant milks statement and 80% (n = 24) with the low
protein milk replacements statement (Table 2). Other low
protein special foods were also discussed in detail and it
was agreed that the initial statement in Phase 1 required
elaboration due to significant protein containing ingredi-
ents in some products.
Phase 3: Round 1 of Delphi method
A statement regarding low protein special foods was dis-
tributed along with information on their content in May
2018. Results were conclusive and this along with Phase
2 statements were agreed at a BIMDG dietitians meeting
in June 2018. A summary of all agreed guidelines was is-
sued in July 2018 and endorsed by the NSPKU (Table 5).
Discussion
National consensus statements on the practical inter-
pretation of dietary management in PKU are central to
ensuring consistent advice is given to all families and
patients with PKU. We have systematic agreement on
many basic dietary rules and definitions which have
received united support from BIMDG dietitians. Using
the Delphi method allowed all BIMDG dietitians to
have the opportunity to give their opinion and influ-
ence several areas of dietary management in PKU
where scientific evidence was unavailable to dictate
practice. For most of the statements, clear consensus
was reached in the first round of Delphi discussions,
leaving only 4 controversial statements requiring more
extensive discussion and negotiation. The process we
Table 5 Summary of Final Consensus Statements for PKU
1. Any food given without measurement is referred to as an exchange-free food.
2. Foods are ‘exchange-free’ if they contain protein ≤0.5 g/100 g. e.g. sweets, coconut products, foods containing gelatine.
Exceptions:
• herbs, spices, seasonings, fats (oil, butter, margarine) – as the quantity used is very small.
• Any soya sauce containing protein ≤1.5 g/100 ml is exchange-free.
• Any ‘wet cooking sauce’ containing protein ≤1.0 g/100 g is exchange-free. If it contains > 1 g protein/100 g and contains exchange ingredients
(e.g. cream, egg, coconut) it should be counted as an exchange food. If it contains > 1 g protein/100 g and contains ‘exchange free’ ingredients only
(e.g. vegetables such as tomatoes) it is an exchange-free food.
3. ‘European PKU guideline 2017’ [3] is used for fruit and vegetable allocation:
• Phe content ≤75 mg/100 g weight of fruit and vegetables: exchange-free.
• Phe content ≥76 mg/100 g weight of fruit and vegetables: count as exchange foods.
Exception:
Potatoes – use Phe analysis to determine exchange amounts. If potato products contain additional exchange ingredients (e.g. wheat flour, or milk),
use protein analysis on the packet to determine its exchange amount.
4. A standard exchange amount of 60 g for any fruit/vegetables containing Phe between 76 and 99 mg/100 g will be used. For any fruit/
vegetables containing Phe ≥100 mg/100 g (e.g. peas, sweetcorn), the actual Phe content will be used to calculate exchange amounts.
5. If any frozen/canned product is designated ‘exchange-free’ in their fresh form, they are considered exchange-free foods e.g. carrots,
mushrooms, tomatoes.
Exception:
Vegetable crisps - although derived from exchange-free food, are concentrated in protein due to cooking methods so should be counted as
exchange foods. Use protein content per 100 g to determine the amount
that can be given for one exchange.
6. Low protein special products (e.g. bread, flour) are exchange-free if all ingredients are exchange-free. If they contain exchange ingredients
but contains ≤25 mg Phe/100 g, they are exchange-free. If they contain exchange ingredients but contains ≥26 mg Phe/100 g, they are an
exchange food.
7. Any low protein special milk that provides a total Phe intake of > 25 mg (1/2 exchange) over 24 h in the volumes consumed, should be counted
as an exchange food. If the total Phe intake provides ≤25 mg over 24 h, it should be considered exchange-free.
8. Any plant milk (e.g. coconut, rice, almond) that provides a total protein intake of > 0.5 g over 24 h in the volumes consumed, should be counted
as an exchange food. If the total protein intake provides ≤0.5 g/100 g over 24 h, it should be considered exchange-free.
9. Soups that contain exchange-free ingredients are exchange-free. If soups contain exchange ingredients and their protein content is > 0.5 g/
100 g, then they should be counted as an exchange food.
10. Weight rather than the volume of ice-cream should be used to calculate the protein exchange amount.
11. Food ‘exchange’ amounts for food portions should be rounded up or down based on the ‘rule of maths’. See Table 3
12. All patients/caregivers are advised to read ingredient lists as well the protein content/100 g on food labels.
If ingredients are protein containing (but the protein analysis appears very low), it is important to establish more accurate protein analysis
before consuming.
If ingredients are ‘clearly’ exchange-free, then it is appropriate to give as an exchange-free food even if the protein analysis is unavailable on the label.
If there is no nutritional analysis on the product but it contains ingredients that are exchange foods, then further food protein analysis must be
obtained before consuming.
If a label states protein content is 0 g but one or more ingredients is a protein source (e.g. gelatine), then an accurate food protein analysis must be
obtained before consuming.
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have undertaken should lead to harmonization and
consistency of dietetic practice in PKU with less confusion
for professionals, patients and their families. Adoption of
these consensus statements by the national patient’s soci-
ety, NSPKU, will enable uniform written dietary informa-
tion to be available for all patients. Further adaptation of
these statements is necessary for maternal PKU, where
dietary management practices are particularly rigorous.
This exercise will be taken forward by the BIMDG dieti-
tians working in adult practice.
The advantage of the Delphi method is that it
involves the collective knowledge of a group of experts
which is likely to be better than that of each individ-
ual; comparing, contrasting, challenging and comple-
menting each other [8]. The process is directed,
impartial, helps engender group ownership, encour-
ages consensus among individuals with diverse views
and is an alternative to conventional meetings where
strong personalities, status and group pressures can
influence individual responses [7]. It was clear that
every opinion was valued and would be important in
influencing the final decisions. Because this method is
structured and focused, it can avoid much of the
counterproductive digressions identifiable in face-to-
face group discussions [7]. Due to the combined
contribution of all members, varying ideas and view-
points were generated and these further directed later
responses.
The Delphi Method did have some limitations. Being a
qualitative method, it is considered subjective. However,
in our consensus statements, only best practice opinion
was available to support any of the specific decisions
reached; when new scientific evidence is available these
statements will be challenged. Also, 70 dietitians partici-
pated, which could be considered a limitation. However,
the number of experts chosen was designed to be inclu-
sive of all centres and dietitians in the UK who were
members of the BIMDG dietitians group. Another draw-
back of the process was the tendency for participants to
maintain the status quo rather than voting for change.
For example, for two of the consensus statements, des-
pite good initial agreement in round 1, further discus-
sion identified the impracticality of the statements which
prompted the generation of 3 possible options for round
2. A further limitation was the lack of response from
some members. Unfortunately, this was unavoidable due
to maternity leave, job changes and retirements occur-
ring during the 18-month period of the project. Some
dietetic non-responders were new to the IMD specialty
or were from centres with fewer patients and or less
clinical experience and may have been reluctant to re-
spond due to uncertainty or a lack of definitive opinion.
Despite some non-responding dietitians, most UK IMD
centres were represented in each round.
Conclusion
In conclusion, this process of agreement between BIMDG
dietitians across the UK will enable the introduction of
consistent, easy-to-understand rules for calculating pro-
tein intake for professionals and patients with PKU. Both
dietitians working in paediatric and adult services have
endorsed these consensus statements which should con-
tribute to a smooth transition between services, maintain-
ing uniformity of information across all ages. Modification
of the consensus statements may be warranted for mater-
nal PKU patients requiring more rigorous dietary restric-
tion. It will be important to perform an evaluation of the
interpretation of these statements by dietitians and
patients in clinical practice. Overall these consensus state-
ments contribute to harmonising dietary advice offered to
British PKU patients. Longitudinal monitoring of their
application, acceptance and adherence by health profes-
sionals and patients or caregivers is essential.
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